Try a new search

Format these results:

Searched for:

in-biosketch:true

person:boswob01

Total Results:

126


Improving the Quality of Colonoscopy Bowel Preparation With a Fellow-Based Colonoscopy Clinic [Meeting Abstract]

Cohen, Michelle; Soumekh, Amir; Bosworth, Brian
ISI:000344383102471
ISSN: 1572-0241
CID: 1861302

Efficacy and Tolerability of Budesonide Foam With or Without Baseline 5-Aminosalicylic Acid Use in Patients With Ulcerative Proctitis (UP) or Ulcerative Proctosigmoiditis (UPS): Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies [Meeting Abstract]

Sandborn, William; Bosworth, Brian; Rubin, David; Yu, Jing; Barrett, Andrew; Paterson, Craig; Forbes, William
ISI:000344383102128
ISSN: 1572-0241
CID: 1861292

Mucosal Response to Ustekinumab in Crohn's Disease [Meeting Abstract]

Novikov, Aleksey; Sriram, Nandita; Rosen, Melissa; Scherl, Ellen; Bosworth, Brian
ISI:000344383102121
ISSN: 1572-0241
CID: 1861282

Cerebral Venous Thrombosis and Inflammatory Bowel Disease: A Case Series [Meeting Abstract]

DeFilippis, Ersilia; Barfield, Elaine; Leifer, Dana; Steinlauf, Adam; Bosworth, Brian; Scherl, Ellen; Sockolow, Robbyn
ISI:000344383101686
ISSN: 1572-0241
CID: 1861262

Early referral for esophageal pH monitoring is more cost-effective than prolonged empiric trials of proton-pump inhibitors for suspected gastroesophageal reflux disease

Kleiman, David A; Beninato, Toni; Bosworth, Brian P; Brunaud, Laurent; Ciecierega, Thomas; Crawford, Carl V Jr; Turner, Brian G; Fahey, Thomas J 3rd; Zarnegar, Rasa
INTRODUCTION: The most cost-effective diagnostic algorithm for gastroesophageal reflux disease (GERD) remains controversial. We hypothesized that prompt referral for esophageal pH monitoring is more cost-effective than prolonged empiric courses of proton-pump inhibitors (PPIs). DISCUSSION: A cost model was created based on a cohort of 100 patients with possible GERD who underwent pH monitoring. The additional costs incurred from pH monitoring were compared to the potential savings from avoiding unnecessary PPI usage in patients with a negative pH study. The costs of PPI therapy reach equivalence with pH monitoring after 6.4 to 23.7 weeks, depending on the PPI regimen. A total of 21,411 weeks of PPIs were prescribed beyond the recommended 8-week trial, of which 32 % were for patients who had a negative 24-h pH monitoring study. If the sensitivity of pH monitoring was 96 %, early referral for pH monitoring would have saved between $1,197 and $6,303 per patient over 10 years. This strategy remains cost-effective as long as the sensitivity of pH monitoring is above 35 %. Prompt referral for pH monitoring after a brief empiric PPI trial is a more cost-effective strategy than prolonged empiric PPI trials for patients with both esophageal and extraesophageal GERD symptoms.
PMID: 24214090
ISSN: 1873-4626
CID: 1859922

Entrustable professional activities for gastroenterology fellowship training [Guideline]

Rose, Suzanne; Fix, Oren K; Shah, Brijen J; Jones, Tamara N; Szyjkowski, Ronald D; Bosworth, Brian P; Bull-Henry, Kathy; Coyle, Walter; Gyawali, C Prakash; Koteish, Ayman; Onken, Jane; Pandolfino, John; Pardi, Darrell; Reddy, Gautham; Richter, Seth; Savides, Thomas J; Sedlack, Robert E
PMID: 24950640
ISSN: 1097-6779
CID: 1859912

ID1 is a functional marker for intestinal stem and progenitor cells required for normal response to injury

Zhang, Ning; Yantiss, Rhonda K; Nam, Hyung-Song; Chin, Yvette; Zhou, Xi Kathy; Scherl, Ellen J; Bosworth, Brian P; Subbaramaiah, Kotha; Dannenberg, Andrew J; Benezra, Robert
LGR5 and BMI1 mark intestinal stem cells in crypt base columnar cells and +4 position cells, respectively, but characterization of functional markers in these cell populations is limited. ID1 maintains the stem cell potential of embryonic, neural, and long-term repopulating hematopoietic stem cells. Here, we show in both human and mouse intestine that ID1 is expressed in cycling columnar cells, +4 position cells, and transit-amplifying cells in the crypt. Lineage tracing revealed ID1+ cells to be self-renewing, multipotent stem/progenitor cells that are responsible for the long-term renewal of the intestinal epithelium. Single ID1+ cells can generate long-lived organoids resembling mature intestinal epithelium. Complete knockout of Id1 or selective deletion of Id1 in intestinal epithelium or in LGR5+ stem cells sensitizes mice to chemical-induced colon injury. These experiments identify ID1 as a marker for intestinal stem/progenitor cells and demonstrate a role for ID1 in maintaining the potential for repair in response to colonic injury.
PMCID:4235234
PMID: 25418719
ISSN: 2213-6711
CID: 1859892

Early Referral for 24-Hour Esophageal pH Monitoring Is More Cost-Effective Than Prolonged Use of Proton Pump Inhibitors in Patients With Suspected Gastroesophageal Reflux Disease [Meeting Abstract]

Kleiman, David; Beninato, Toni; Bosworth, Brian P; Brunaud, Laurent; Ciecierega, Thomas; Crawford, Carl V; Turner, Brian G; Fahey, Thomas J; Zarnegar, Rasa
ISI:000322997206107
ISSN: 0016-5085
CID: 2225702

Clinical Response to Ustekinumab in Crohn's Disease: Results from an Academic Inflammatory Bowel Disease Center [Meeting Abstract]

Novikov, Aleksey; Sriram, Nandita; Rosen, Melissa; Scherl, Ellen; Bosworth, Brian
ISI:000330178102105
ISSN: 1572-0241
CID: 2225712

The Association Between Increased Body Mass Index and Failure of Infliximab Treatment for Inflammatory Bowel Disease [Meeting Abstract]

Tow, Clara Y; Schneider, Yecheskel; Rosen, Melissa H; Bosworth, Brian P
ISI:000322997202387
ISSN: 0016-5085
CID: 2225732